Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 10—October 2020
Research Letter

Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents

Arnaud G. L’Huillier1, Giulia Torriani1, Fiona Pigny, Laurent Kaiser, and Isabella EckerleComments to Author 
Author affiliations: Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Cite This Article


Children do not seem to drive transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We isolated culture-competent virus in vitro from 12 (52%) of 23 SARS-CoV-2–infected children; the youngest was 7 days old. Our findings show that symptomatic neonates, children, and teenagers shed infectious SARS-CoV-2, suggesting that transmission from them is plausible.

Children are underrepresented in coronavirus disease (COVID-19) case numbers (1,2). Severity in most children is limited, and children do not seem to be major drivers of transmission (3,4). However, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects children of all ages (1,3). Despite the high proportion of mild or asymptomatic infections (5), they should be considered as transmitters unless proven otherwise. To address this point, the laboratory of the Geneva University Hospitals and Faculty of Medicine, University of Geneva (Geneva, Switzerland), used cell culture to systematically assess cultivable SARS-CoV-2 in the upper respiratory tract (URT) of 23 children with COVID-19.

All nasopharyngeal specimens (NPS) were collected with a flocked swab in universal transport medium (Floqswab; Copan, and tested for SARS-CoV-2 by reverse transcription PCR during January 25–March 31, 2020 (Appendix). We seeded Vero E6 cells at 8 × 104 cells/well in a 24-well plate and inoculated them with 200 μL of viral transport medium the following day. Cells were inoculated for 1 h at 37°C; inoculum was removed; cells were washed once with phosphate buffered saline; and regular cell growth medium containing 10% fetal calf serum was added. We observed cells on days 2, 4, and 6 for cytopathic effect (CPE) by light microscopy. We harvested supernatant at first observation of CPE or, if no CPE occurred, on day 6. For a second passage, we transferred 20 μL supernatant of CPE-positive specimens onto new Vero E6 cells. We collected supernatant after inoculation and on observation of CPE and confirmed isolation of replication competent SARS-CoV-2 by an increase in viral RNA (Appendix).

Of 638 patients <16 years of age, 23 (3.6%) tested positive for SARS-CoV-2. Median age was 12.0 years (interquartile range [IQR] 3.8–14.5 years, range 7 days–15.9 years). Thirteen patients had an URT infection; 2 each had fever without source and pneumonia (Table). Samples were collected a median of 2 (IQR 1–3) days after symptom onset. Median viral RNA load at diagnosis was 3.0 × 106 copies/mL (mean 4.4 × 108 [IQR 6.9 × 103–4.4 × 108] copies/mL; peak 5.3 × 109 copies/mL).

We isolated SARS-CoV-2 from 12 (52%) children. We determined SARS-CoV-2 isolation by presence of CPE and increased viral RNA in the supernatant (Table; Appendix Figure). SARS-CoV-2 replication in all 12 positive isolates was confirmed by a second passage.


Thumbnail of Severe acute respiratory syndrome coronavirus 2 initial RNA numbers from nasopharyngeal swabs of culture-negative and culture-positive specimens from children &lt;16 years of age, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Switzerland, January 25–March 31, 2020. Thick horizontal bars indicate median RNA; thin horizontal bars indicate interquartile range. Asterisk (*) indicates specimen collected outside the institution, suggesting a longer time to fre

Figure. Severe acute respiratory syndrome coronavirus 2 initial RNA copy numbers from nasopharyngeal swabs of culture-negative and culture-positive specimens from children <16 years of age, Geneva University Hospitals, Geneva, Switzerland, January 25–March...

We isolated virus from children of all ages; the youngest was 7 days of age. Median viral load was higher for patients with isolation (1.7 × 108 [mean 7.9 × 108, IQR 4.7 × 106–1.0 × 109] copies/mL) than for those without isolation (6.9 × 103 [mean 5.4 × 107, IQR 4.2 × 103–1.8 × 106] copies/mL; p = 0.002) (Figure). Sex, age, duration of symptoms, clinical diagnosis, symptoms, and likelihood of admission did not differ between patients with and without isolation (Appendix Table).

Our data show that viral load at diagnosis is comparable to that of adults (6,7) and that symptomatic children of all ages shed infectious virus in early acute illness, a prerequisite for further transmission. Isolation of infectious virus was largely comparable with that of adults, although 2 specimens yielded an isolate at lower viral load (1.2 × 104 and 1.4 × 105 copies/mL) (6).

A limitation of our study was the small number of children assessed. However, although the Canton of Geneva was a region severely affected by SARS-CoV-2 (8), only 23 cases were diagnosed in children at our hospital during the study period. These findings confirm that children are not a major risk group for COVID-19. Another limitation is our reliance solely on leftover material initially received for routine diagnostic purposes that we retrospectively analyzed. Using such specimens has several disadvantages: preanalytic quality of specimens could be affected by suboptimal times between sample collection and storage at −80°C because of transport and diagnostic processing time, resulting in loss in infectivity and failure of virus isolation even in the presence of high viral load. Therefore, our findings probably underestimate the true rate of infectious virus presence in symptomatic children, and we cannot comment whether our data reflect the rates of infectious virus shedding in the community. Because of the limited leftover volume of the specimens, we were unable to further investigate the quantity of infectious viral particles. Most patients were managed as outpatients and self-isolated at home, so no consecutive sampling was possible to assess infectious virus in multiple samples over the course of disease.

SARS-CoV-2 viral load and shedding patterns of culture-competent virus in 12 symptomatic children resemble those in adults. Therefore, transmission of SARS-CoV-2 from children is plausible. Considering the relatively low frequency of infected children, even in severely affected areas, biological or other unknown factors could lead to the lower transmission in this population. Large serologic investigations and systematic surveillance for acute respiratory diseases and asymptomatic presentations are needed to assess the role of children in this pandemic.

Dr. L’Huillier is a junior staff physician at Geneva University Hospitals and Faculty of Medicine, University of Geneva. His primary research interests include emerging viruses and transplant virology.



We thank Manel Essaidi-Laziosi for her help with the laboratory work and Erik Boehm for help with editing the manuscript.



  1. Livingston  E, Bucher  K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020;323:1335. DOIPubMedGoogle Scholar
  2. Qiu  H, Wu  J, Hong  L, Luo  Y, Song  Q, Chen  D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:68996. DOIPubMedGoogle Scholar
  3. Lu  X, Zhang  L, Du  H, Zhang  J, Li  YY, Qu  J, et al.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:16635. DOIPubMedGoogle Scholar
  4. World Health Organization. Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID-19). 28 February 2020 [cited 2020 Jun 29].
  5. Parri  N, Lenge  M, Buonsenso  D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in pediatric emergency departments in Italy. N Engl J Med. 2020;•••:NEJMc2007617; Epub ahead of print. DOIPubMedGoogle Scholar
  6. Wölfel  R, Corman  VM, Guggemos  W, Seilmaier  M, Zange  S, Müller  MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:4659. DOIPubMedGoogle Scholar
  7. Jones  TC, Mühlemann  B, Veith  T, Zuchowski  M, Hofmann  J, Stein  A, et al. An analysis of SARS-CoV-2 viral load by patient age [cited 2020 May 3].
  8. Stringhini  S, Wisniak  A, Piumatti  G, Azman  AS, Lauer  SA, Baysson  H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;S0140-6736(20)31304-0; [Epub ahead of print].PubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2610.202403

Original Publication Date: June 30, 2020

1These authors contributed equally to this article.

Table of Contents – Volume 26, Number 10—October 2020

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Isabella Eckerle, Laboratory of Virology and Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, 4 Rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland

Send To

10000 character(s) remaining.


Page created: June 30, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.